According to de Jong et al., a little variation was seen in the dextromethorphan metabolic ratio (CYP2D6 substrate), suggesting that the levels of CYP2D6 MR are not influenced by obesity/bariatric surgery. The gene discussed is CYP2D6; the disease is obesity disorder.